The quality of life of the glaucoma patient in the light of treatment modalities

Publisher Website
Google Scholar
Abstract
Glaucoma is the second leading cause of blindness in the United States. The cost of this disease in suffering and dollars is great for patients and society. The disease and its treatment may have an enormous impact on the patient's quality of life. The label of glaucoma alone may induce anxiety and depression. Topical medications, oral medications, and surgical treatment may produce adverse effects that have significant consequences for the patient. This article reviews the adverse effects of p-blockers, miotics, carbonic anhydrase inhibitors, and surgical treatment and the relationship of these adverse effects to the patient's quality of life. It is sometimes difficult to determine whether these treatments are more detrimental than the disease itself. The true goal of any treatment is to minimize the “dis” “ease” of patients and attempt to make them whole.

This publication has 0 references indexed in Scilit: